We are live on ! Find out more
IRMD icon

iRadimed

59 hedge funds and large institutions have $63.7M invested in iRadimed in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

16% more capital invested

Capital invested by funds: $54.7M → $63.7M (+$8.95M)

9% more funds holding

Funds holding: 5459 (+5)

2.66% more ownership

Funds ownership: 23.99%26.65% (+2.7%)

Holders
59
Holders Change
+5
Holders Change %
+9.26%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
25
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change

IRMD Hedge Fund Activity: Q3 2019 in Review

59 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2019, worth a combined $63.7M — up 16% from $54.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IRMD positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $1.46M. The largest seller was Navellier & Associates, cutting an estimated $2.11M.

  • 59 institutional investors held iRadimed (IRMD) as of Q3 2019, up from 54 in Q2 2019.
  • Funds reported $63.7M of iRadimed stock for Q3 2019, up 16% quarter-over-quarter.
  • 12 funds opened new iRadimed positions in Q3 2019 and 7 closed out, a net change of +5 holders.
  • The largest iRadimed buyer in Q3 2019 was Nuveen, an estimated $1.46M added.
  • The largest iRadimed seller in Q3 2019 was Navellier & Associates, an estimated $2.11M sold.

Based on aggregated 13F filings for Q3 2019.